These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 17686073)

  • 1. Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients.
    Pelaez-Luna M; Chari ST; Smyrk TC; Takahashi N; Clain JE; Levy MJ; Pearson RK; Petersen BT; Topazian MD; Vege SS; Kendrick M; Farnell MB
    Am J Gastroenterol; 2007 Aug; 102(8):1759-64. PubMed ID: 17686073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Branch duct intraductal papillary mucinous neoplasm of the pancreas in solid organ transplant recipients.
    Gill KR; Pelaez-Luna M; Keaveny A; Woodward TA; Wallace MB; Chari ST; Smyrk TC; Takahashi N; Clain JE; Levy MJ; Pearson RK; Petersen BT; Topazian MD; Vege SS; Kendrick M; Farnell MB; Raimondo M
    Am J Gastroenterol; 2009 May; 104(5):1256-61. PubMed ID: 19352341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-institution validation of the international consensus guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas.
    Nagai K; Doi R; Ito T; Kida A; Koizumi M; Masui T; Kawaguchi Y; Ogawa K; Uemoto S
    J Hepatobiliary Pancreat Surg; 2009; 16(3):353-8. PubMed ID: 19280108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules.
    Sadakari Y; Ienaga J; Kobayashi K; Miyasaka Y; Takahata S; Nakamura M; Mizumoto K; Tanaka M
    Pancreas; 2010 Mar; 39(2):232-6. PubMed ID: 19752768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical fate of branch duct and mixed forms of intraductal papillary mucinous neoplasia of the pancreas.
    Bournet B; Kirzin S; Carrère N; Portier G; Otal P; Selves J; Musso C; Suc B; Moreau J; Fourtanier G; Pradère B; Lazorthes F; Escourrou J; Buscail L
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1211-7. PubMed ID: 19476563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Branch duct intraductal papillary mucinous neoplasms in a retrospective series of 190 patients.
    Woo SM; Ryu JK; Lee SH; Yoon WJ; Kim YT; Yoon YB
    Br J Surg; 2009 Apr; 96(4):405-11. PubMed ID: 19283746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes after pancreatectomy for intraductal papillary mucinous neoplasms of the pancreas: an institutional experience.
    Yang AD; Melstrom LG; Bentrem DJ; Ujiki MB; Wayne JD; Strouch M; Bell RH; Rao SM; Talamonti MS
    Surgery; 2007 Oct; 142(4):529-34; discussion 534-7. PubMed ID: 17950345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification.
    Serikawa M; Sasaki T; Fujimoto Y; Kuwahara K; Chayama K
    J Clin Gastroenterol; 2006 Oct; 40(9):856-62. PubMed ID: 17016145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas.
    Uehara H; Nakaizumi A; Ishikawa O; Iishi H; Tatsumi K; Takakura R; Ishida T; Takano Y; Tanaka S; Takenaka A
    Gut; 2008 Nov; 57(11):1561-5. PubMed ID: 18477671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: when can we operate or observe?
    Jang JY; Kim SW; Lee SE; Yang SH; Lee KU; Lee YJ; Kim SC; Han DJ; Choi DW; Choi SH; Heo JS; Cho BH; Yu HC; Yoon DS; Lee WJ; Lee HE; Kang GH; Lee JM
    Ann Surg Oncol; 2008 Jan; 15(1):199-205. PubMed ID: 17909912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic-duct-lavage cytology in candidates for surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas: should the International Consensus Guidelines be revised?
    Sai JK; Suyama M; Kubokawa Y; Watanabe S; Maehara T
    Gastrointest Endosc; 2009 Mar; 69(3 Pt 1):434-40. PubMed ID: 18684453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas.
    Fritz S; Schirren M; Klauss M; Bergmann F; Hackert T; Hartwig W; Strobel O; Grenacher L; Büchler MW; Werner J
    Surgery; 2012 Sep; 152(3 Suppl 1):S74-80. PubMed ID: 22770954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphologic changes in branch duct intraductal papillary mucinous neoplasms of the pancreas: a midterm follow-up study.
    Rautou PE; Lévy P; Vullierme MP; O'Toole D; Couvelard A; Cazals-Hatem D; Palazzo L; Aubert A; Sauvanet A; Hammel P; Hentic O; Rebours V; Pelletier AL; Maire F; Ruszniewski P
    Clin Gastroenterol Hepatol; 2008 Jul; 6(7):807-14. PubMed ID: 18304885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade.
    Michaels PJ; Brachtel EF; Bounds BC; Brugge WR; Pitman MB
    Cancer; 2006 Jun; 108(3):163-73. PubMed ID: 16550572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential diagnosis of benign or malignant intraductal papillary mucinous neoplasm of the pancreas by multidetector row helical computed tomography: evaluation of predictive factors by logistic regression analysis.
    Takeshita K; Kutomi K; Takada K; Haruyama T; Fukushima J; Aida R; Takada T; Furui S
    J Comput Assist Tomogr; 2008; 32(2):191-7. PubMed ID: 18379300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas.
    Hirono S; Tani M; Kawai M; Okada K; Miyazawa M; Shimizu A; Kitahata Y; Yamaue H
    Ann Surg; 2012 Mar; 255(3):517-22. PubMed ID: 22301608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of intraoperative cytology combined with histology in detecting continuous and skip type intraductal cancer existence for intraductal papillary mucinous carcinoma of the pancreas.
    Eguchi H; Ishikawa O; Ohigashi H; Sasaki Y; Yamada T; Nakaizumi A; Uehara H; Takenaka A; Kasugai T; Imaoka S
    Cancer; 2006 Dec; 107(11):2567-75. PubMed ID: 17054109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results.
    Tanno S; Nakano Y; Nishikawa T; Nakamura K; Sasajima J; Minoguchi M; Mizukami Y; Yanagawa N; Fujii T; Obara T; Okumura T; Kohgo Y
    Gut; 2008 Mar; 57(3):339-43. PubMed ID: 17660227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas.
    Schnelldorfer T; Sarr MG; Nagorney DM; Zhang L; Smyrk TC; Qin R; Chari ST; Farnell MB
    Arch Surg; 2008 Jul; 143(7):639-46; discussion 646. PubMed ID: 18645105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology.
    Schmidt CM; White PB; Waters JA; Yiannoutsos CT; Cummings OW; Baker M; Howard TJ; Zyromski NJ; Nakeeb A; DeWitt JM; Akisik FM; Sherman S; Pitt HA; Lillemoe KD
    Ann Surg; 2007 Oct; 246(4):644-51; discussion 651-4. PubMed ID: 17893501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.